Neff R Matthew 4/A
4/A · BIOANALYTICAL SYSTEMS INC · Filed Jan 12, 2021
Insider Transaction Report
Form 4/AAmended
Neff R Matthew
Director
Transactions
- Purchase
Common Shares
2020-03-13$3.93/sh+3,350$13,166→ 43,430 total - Purchase
Common Shares
2020-03-12$3.80/sh+8,497$32,289→ 40,080 total
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.92 to $3.95, inclusive. The reporting person undertakes to provide to Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The reporting person is filing this amendment to correct the number of securities reported as purchased on March 12, 2020.